MedTrace Logo

Health Outcomes for Acute Concussion

NCT04087434 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-09-12

No results posted yet for this study

Summary

The primary purpose of this prospective observational trial is to validate the Brain Gauge device as an objective tool for concussion assessment and treatment in order to determine if a method that has proven successful in 18-22 year old collegiate student-athletes will be applicable for military personnel. Overall aims of the study include:

1. Demonstration that the Brain Gauge can objectively measure concussion in this population and thus improve concussion identification and coding.
2. Demonstration of stronger screening for and tracking of acute concussion and documentation of concussion diagnoses, including improved tracking of recovery and greater adherence to DOD/VA Clinical Practice Guidelines for acute concussion.

Conditions

  • Brain Injury, Acute

Interventions

DEVICE

Brain Gauge Prospective and Healthy Control

The Brain Gauge is a brain health assessment system that takes advantage of the well-documented relationship between the sensory nerves in the fingers and the projection of those nerves to corresponding regions in the brain. The system is composed of a test device (the Brain Gauge) that uses novel fingertip vibration patterns to probe cortical complexity and utilize that complexity to gain more sensitive and specific detection of compromised neural function.

Sponsors & Collaborators

  • The Defense and Veterans Brain Injury Center

    collaborator FED

  • Kendra Jorgensen-Wagers

    lead FED

Principal Investigators

  • Kendra L Jorgensen-Wagers, Ph.D · The Defense and Veterans Brain Injury Center

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-18
Primary Completion
2020-01-10
Completion
2020-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04087434 on ClinicalTrials.gov